SCHEMBL7254585

SCHEMBL7254585

O=C1CSC(c2cccc(F)c2)N1CCCN1CCN(c2ncccn2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.59
DRD2 P14416 7/20 0.48
DRD3 P35462 6/20 0.48
HTR1A P08908 5/20 0.48
HTR2A P28223 5/20 0.48
DRD1 P21728 3/20 0.48
DRD5 P21918 2/20 0.48
ALDH1A1 P00352 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
HSD17B10 Q99714 1/20 0.47
CACNA1B Q00975 2/20 0.46
GFER P55789 1/20 0.46
DRD4 P21917 3/20 0.45
ADRA2C P18825 1/20 0.45
HTR2C P28335 1/20 0.45
HRH1 P35367 1/20 0.45
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7247654 0.89 ACHE (0.56) ACHEDRD2DRD3HTR1AHTR2A
SCHEMBL7254170 0.88 ACHE (0.59) ACHEDRD2DRD3HTR1ACACNA1B
SCHEMBL7253159 0.87 CACNA1B (0.63) ACHEDRD2DRD3HTR1ACACNA1B
SCHEMBL7250409 0.85 ACHE (0.64) ACHEALDH1A1HSD17B10GFERNPSR1
SCHEMBL7248250 0.81 ACHE (0.58) ACHEALDH1A1GFERNPSR1
SCHEMBL7255245 0.81 ACHE (0.71) ACHEALDH1A1CACNA1BGFER
SCHEMBL7249425 0.78 ACHE (0.71) ACHEALDH1A1KMT2AGFER
SCHEMBL7254140 0.78 ACHE (0.56) ACHEDRD2DRD3HTR1AHTR2A
SCHEMBL7248634 0.76 HTR1A (0.41) DRD2DRD3HTR1AHTR2ADRD1
SCHEMBL7248632 0.76 HTR1A (0.41) DRD2DRD3HTR1AHTR2ADRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506751-B1 The compounds are useful in the treatment and prevention of the AIDS virus. Intermediates useful in the preparation of the final products, pharmaceutical compositions containing the final products are also taught. invention is directed to MILLENNIUM PHARMACEUTICALS, INC. 2003-01-14 US disclosed